President Trump announced that generic drugs imported into the U.S. will remain tariff-free for two years beginning August 1, 2026, before tariffs rise to 100% for one year and 200% thereafter, as part of an effort to move generic drug production to the United States.
DRUG TARIFFS: Trump Announces Two-Year Tariff Exemption Before Rates Rise to 200%
